Compare WYETH with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs DR. REDDYS LAB - Comparison Results

WYETH     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH DR. REDDYS LAB WYETH/
DR. REDDYS LAB
 
P/E (TTM) x 27.7 34.3 80.9% View Chart
P/BV x 5.3 4.7 114.1% View Chart
Dividend Yield % 1.3 0.6 224.9%  

Financials

 WYETH   DR. REDDYS LAB
EQUITY SHARE DATA
    WYETH
Mar-13
DR. REDDYS LAB
Mar-20
WYETH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0443,363 31.1%   
Low Rs8182,352 34.8%   
Sales per share (Unadj.) Rs298.61,054.2 28.3%  
Earnings per share (Unadj.) Rs57.2121.9 46.9%  
Cash flow per share (Unadj.) Rs58.4190.2 30.7%  
Dividends per share (Unadj.) Rs17.0025.00 68.0%  
Dividend yield (eoy) %1.80.9 208.7%  
Book value per share (Unadj.) Rs249.5938.7 26.6%  
Shares outstanding (eoy) m22.72166.17 13.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.12.7 115.1%   
Avg P/E ratio x16.323.4 69.4%  
P/CF ratio (eoy) x15.915.0 106.1%  
Price / Book Value ratio x3.73.0 122.6%  
Dividend payout %29.720.5 144.8%   
Avg Mkt Cap Rs m21,157474,831 4.5%   
No. of employees `0000.521.7 2.3%   
Total wages/salary Rs m40033,802 1.2%   
Avg. sales/employee Rs Th13,787.48,091.0 170.4%   
Avg. wages/employee Rs Th813.01,561.3 52.1%   
Avg. net profit/employee Rs Th2,643.3935.8 282.5%   
INCOME DATA
Net Sales Rs m6,783175,170 3.9%  
Other income Rs m3536,206 5.7%   
Total revenues Rs m7,136181,376 3.9%   
Gross profit Rs m1,61724,421 6.6%  
Depreciation Rs m2711,348 0.2%   
Interest Rs m6983 0.6%   
Profit before tax Rs m1,93818,296 10.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-1,403 -45.1%   
Profit after tax Rs m1,30120,260 6.4%  
Gross profit margin %23.813.9 171.0%  
Effective tax rate %32.6-7.7 -425.4%   
Net profit margin %19.211.6 165.8%  
BALANCE SHEET DATA
Current assets Rs m6,984125,991 5.5%   
Current liabilities Rs m2,05672,141 2.8%   
Net working cap to sales %72.630.7 236.3%  
Current ratio x3.41.7 194.5%  
Inventory Days Days9973 135.8%  
Debtors Days Days24105 22.9%  
Net fixed assets Rs m24483,854 0.3%   
Share capital Rs m227831 27.3%   
"Free" reserves Rs m5,441155,157 3.5%   
Net worth Rs m5,668155,988 3.6%   
Long term debt Rs m251,304 1.9%   
Total assets Rs m7,901232,253 3.4%  
Interest coverage x353.319.6 1,801.5%   
Debt to equity ratio x00 52.8%  
Sales to assets ratio x0.90.8 113.8%   
Return on assets %16.59.1 180.7%  
Return on equity %22.913.0 176.7%  
Return on capital %34.012.6 269.9%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1584,193 0.0%   
Fx outflow Rs m2,67739,616 6.8%   
Net fx Rs m-2,66244,577 -6.0%   
CASH FLOW
From Operations Rs m92329,841 3.1%  
From Investments Rs m317-4,923 -6.4%  
From Financial Activity Rs m-481-25,159 1.9%  
Net Cashflow Rs m759-266 -285.4%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 5.4 209.3%  
FIIs % 7.2 35.3 20.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 30.4 15.3 198.7%  
Shareholders   21,978 75,885 29.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare WYETH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 200 Points Higher; Dow Futures Down by 90 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 209 points, up 0.4% at 50,058 levels.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WYETH SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH

COMPARE WYETH WITH

MARKET STATS